Clinical Webinar: Fall & Winter Vaccines
In this month’s Rx Care Insights episode, Erin Donatelli, PharmD, BCGP, FASCP and Sarah Griffie, PharmD, BCGP cover the five vaccines every long-term care facility should have on its radar this season: influenza, COVID-19, RSV, pneumococcal, and shingles, along with CMS requirements under F883 and F887, Medicare Part B versus Part D billing, and storage and co-administration guidance.
Medications to WatchÂ
In this issue of Medications to Watch, our clinical pharmacy team rounds up the generic launches, brand approvals, and new FDA drug approvals most relevant to long-term care. Highlights include upcoming generics for Januvia, Xeljanz XR, and Edarbi, new indications for Mounjaro and Kerendia, and 2026 novel approvals such as once-weekly basal insulin and the first oral PCSK9 drug.
2026 Volume 1
CMS is sharpening its focus on antipsychotic use in long-term care, and the implications for your facility go beyond compliance. This volume examines what the new measure means for your team. This edition of the Clarest Pulse also offers ways to maximize the value of your consultant pharmacist, discusses why medication adherence breaks down for seniors at home, and shares details of our new offering, Clarest at Home.
